Evidence map›Paper›PMID 38026943›Full record

ArticleFrontiers in pharmacology2023

Investigating the role of NPR1 in dilated cardiomyopathy and its potential as a therapeutic target for glucocorticoid therapy.

Yaomeng Huang, Tongxin Li, Shichao Gao, Shuyu Li, Xiaoran Zhu, Ying Li, Dangyang Liu, Weimin Li, Linquan Yang, Kunshen Liu and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yaomeng Huang *Laboratory Center, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Tongxin Li *The First Cardiology Division, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Shichao Gao *Laboratory Center, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Shuyu LiDepartment of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei, China.
Xiaoran ZhuDepartment of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebeie, China.
Ying LiThe First Cardiology Division, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Dangyang LiuThe First Cardiology Division, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Weimin LiThe First Cardiology Division, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Linquan YangDepartment of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebeie, China.
Kunshen LiuThe First Cardiology Division, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Zheng ZhangLaboratory Center, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Chao LiuThe First Cardiology Division, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Hebei Medical University · CNHebei General Hospital · CNTangshan Gongren Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dilated cardiomyopathyglucocorticoidnatriuretic peptide receptor 1SsGSEAWGCNA

Identifiers

PMID38026943
PMCPMC10662320
OpenAlexW4388459017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.